Neuregulin1 ameliorates metabolic dysfunction-associated fatty liver disease via the ERK/SIRT1 signaling pathways | BMC Gastroenterology
Unraveling the Future of Animal Experimentation in Biomedical Research The sphere of biomedical research is evolving rapidly, driven by advances in technology and growing ethical considerations. One area under significant scrutiny and development is the use of animal models, particularly in studying complex human diseases like non-alcoholic fatty liver disease (NAFLD). Recent studies, such as … Read more